ImVisioN GmbH Starts Phase I Clinical Trial of IVN201
9/10/2008 2:06:02 PM
More...
|
ImVisioN GmbH Obtains An Exclusive License From MannKind Corporation (MNKD) To Patents Covering The Intralymphatic Administration Off Allergens
3/2/2006 1:02:06 PM
More...
|
BioVisioN AG Spins Off New Enterprise With Peptide Vaccine Portfolio
10/19/2005 5:12:22 PM
More...
|
BioVisioN AG Sells Its Subsidiary ImVisioN GmbH To Nextech Venture
10/19/2005 5:10:38 PM
More...
|
ImVisioN GmbH Appoints Martin Steiner As CEO And Acquires Broad IP Portfolio
10/19/2005 5:09:51 PM
More...
|